Real-World Data Question Low-Dose Steroid Use in Vasculitis

Patients with ANCA-associated vasculitis receiving low glucocorticoid doses as per the PEXIVAS trial faced an increased risk for death, renal failure, progression, or relapse in this real-world study.
Medscape Medical News

source https://www.medscape.com/viewarticle/real-world-data-question-low-dose-steroid-use-vasculitis-2024a1000mm6?src=rss

Comments

Popular posts from this blog

RA and RA-ILD Linked to Higher Lung Cancer Risk

New AAFP practice guideline sets blood pressure targets for adults with hypertension

Heart Failure Care Outside of ICU Can Lower Cost